Patent: 5,306,509
✉ Email this page to a colleague
Summary for Patent: 5,306,509
Title: | Prevention and treatment of oral lesions |
Abstract: | The present invention involves a preparation adapted for prophylaxis and treatment of oral lesions, The preparation comprises water, between about 0.1% and about 0.8% hydrogen peroxide and between about 0.1% and about 0.4% sodium bicarbonate. In more preferable embodiments of the present invention, the hydrogen peroxide is about 0.4% and the sodium bicarbonate is about 0.2%. Additionally, a method for prophylaxis and treatment of oral lesions is included in the present invention. This method involves the step of initially providing a preparation preferably comprising water, between about 0.1% and about 0.8% hydrogen peroxide and between about 0.1% and about 0.4% sodium bicarbonate. Oral rinsing with said preparation, particularly multiple daily oral rinsing, enhances healing of oral lesions and impedes or prevents the development of oral lesions such as, for example, those frequently incident to cancer chemotherapy. SOL also appears to be dental plaque retardant. The clinical crowns of the patients teeth appear to be free of debris during the periods of significant myelosuppression when dental flossing and toothbrushing should not and were not performed. |
Inventor(s): | Turner; Robert E. (Coraopolis, PA) |
Assignee: | |
Application Number: | 07/423,500 |
Patent Claims: | see list of patent claims |
Details for Patent 5,306,509
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | ZOSTAVAX | zoster vaccine live | For Injection | 125123 | 05/25/2006 | ⤷ Try a Trial | 2011-04-26 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |